Newbridge Financial Services Group’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $133K | Buy |
+5,000
| New | +$133K | 0.02% | 343 |
|
|
2025
Q1 | – | Sell |
-50
| Closed | -$2.01K | – | 1162 |
|
|
2024
Q4 | $2.01K | Sell |
50
-25
| -33% | -$1.01K | ﹤0.01% | 970 |
|
|
2024
Q3 | $4.75K | Hold |
75
| – | – | ﹤0.01% | 510 |
|
|
2024
Q2 | $3.98K | Sell |
75
-25
| -25% | -$1.33K | ﹤0.01% | 880 |
|
|
2024
Q1 | $8.2K | Sell |
100
-100
| -50% | -$8.2K | ﹤0.01% | 809 |
|
|
2023
Q4 | $3.72K | Buy |
200
+100
| +100% | +$1.86K | ﹤0.01% | 895 |
|
|
2023
Q3 | $1.11K | Hold |
100
| – | – | ﹤0.01% | 1147 |
|
|
2023
Q2 | $1.62K | Buy |
+100
| New | +$1.62K | ﹤0.01% | 1163 |
|